The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,791,246 in first-year total cost, median $440,000.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-G (60)]13
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- HUGO W. MOSER RES INST KENNEDY KRIEGER1
- MAYO CLINIC ROCHESTER1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Vanderbilt Site for Network of Excellence in Neuroscience Clinical Trials2U24NS107128-06 | CHARLES, PHILIP DAVIDPELTIER, AMANDA C | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $481,250 | ZNS1 |
| 2023 | Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)2U24NS107168-06 | CHIRIBOGA, CLAUDIA AMARDER, KAREN SSARVA, HARINI | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $469,300 | ZNS1 |
| 2023 | The Mayo Clinic NeuroNEXT Clinical Research Site1U24NS133986-01 | STAFF, NATHAN P | MAYO CLINIC ROCHESTER, MN | $469,296 | ZNS1 |
| 2023 | Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site1U24NS134009-01 | AUGUSTINE, ERIKAMOWRY, ELLEN M. | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $462,227 | ZNS1 |
| 2023 | Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)2U24NS107200-06 | GLAUSER, TRACY AWOO, DANIEL | UNIVERSITY OF CINCINNATI, OH | $460,240 | ZNS1 |
| 2023 | Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT site)2U24NS107213-06 | SIMUNI, TANYA | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $451,293 | ZNS1 |
| 2023 | NINDS Network for Excellence in Neuroscience: Clinical Research Site at UC Davis2U24NS107209-06 | MCDONALD, CRAIG M. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $440,000 | ZNS1 |
| 2023 | Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)2U24NS107166-06 | CLEMENS, PAULA R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $433,710 | ZNS1 |
| 2023 | University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.1U24NS133991-01 | BENKE, TIMOTHY ABENNETT, JEFFREY LPIQUET, AMANDA L | UNIVERSITY OF COLORADO DENVER, CO | $428,955 | ZNS1 |
| 2023 | Wake Forest NeuroNext Clinical Site (WAKENN)2U24NS107197-06 | EZZEDDINE, MUSTAPHA AHMADSTROWD, ROY ERVIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $426,250 | ZNS1 |
| 2023 | University of Rochester Clinical Site within the NEXT Network of Clinical Trials2U24NS107165-06 | HOLLOWAY, ROBERT G. | UNIVERSITY OF ROCHESTER, NY | $423,500 | ZNS1 |
| 2023 | The Utah Regional Network for Excellence in Neuroscience Clinical Trials (UR-NEXT)2U24NS107156-06 | BONKOWSKY, JOSH LEITCHSINGLETON, JOHN ROBINSON | UNIVERSITY OF UTAH, UT | $423,100 | ZNS1 |
| 2023 | Clinical Centers for the NINDS NeuroNEXT(Network of Excellence in Neuroscience Clinical Trials) Consortium2U24NS107376-06 | BENATAR, MICHAEL | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $422,125 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.